Nutanix, Inc.
Financial highlights
| Metric | FY 07/31/25 | FY 07/31/24 | FY 07/31/23 | FY 07/31/22 | FY 07/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.5B | $2.1B | $1.9B | $1.6B | $1.4B |
| Cost of revenue | $334.8M | $324.1M | $332.2M | $321.2M | $291.9M |
| Gross profit | $2.2B | $1.8B | $1.5B | $1.3B | $1.1B |
| Research and development | $736.8M | $639.0M | $581.0M | $573.0M | $558.0M |
| Operating expenses | $2.0B | $1.8B | $1.7B | $1.7B | $1.8B |
| Operating income | $172.5M | $7.6M | -$207.2M | -$458.9M | -$662.1M |
| Pretax income | $211.6M | -$101.3M | -$233.6M | -$779.7M | -$1.0B |
| Income tax expense | $23.3M | $23.5M | $21.0M | $19.3M | $18.5M |
| Net income | $188.4M | -$124.8M | -$254.6M | -$798.9M | -$1.0B |
| Balance Sheet | |||||
| Cash and equivalents | $769.5M | $655.3M | $512.9M | $402.9M | $285.7M |
| Current assets | $2.6B | $1.5B | $1.9B | $1.7B | $1.6B |
| Total assets | $3.3B | $2.1B | $2.5B | $2.4B | $2.3B |
| Current liabilities | $1.4B | $1.2B | $1.1B | $1.2B | $927.9M |
| Total liabilities | $4.0B | $2.9B | $3.2B | $3.2B | $3.3B |
| Stockholders' equity | -$694.5M | -$728.1M | -$707.4M | -$800.5M | -$1.0B |
| Cash Flow Statement | |||||
| Cash from operations | $821.5M | $672.9M | $272.4M | $67.5M | -$99.8M |
| Depreciation and amortization | $72.7M | $73.2M | $76.4M | $88.0M | $94.4M |
| Stock-based compensation | $351.6M | $333.8M | $311.7M | $343.2M | $358.5M |
| Capital expenditure | $71.3M | $75.3M | $65.4M | $49.1M | $58.6M |
| Free cash flow | $750.2M | $597.7M | $207.0M | $18.5M | -$158.5M |
| Share repurchases | $307.9M | $131.1M | $0 | $58.6M | $125.1M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 270.3M · Free float 91.0%
Annual filing data through FY ended July 31, 2025; float as of July 14, 2026.